NASDAQ:GBT
Delisted

Global Blood Therapeutics Stock News

etoro logo Buy GBT
*Your capital is at risk
$68.49
+0 (+0%)
At Close: Jan 27, 2023
Experimental genetic treatments could hold the key to a better quality of life for patients and long-term returns for CRISPR stock.
Deutsche Bank AG lessened its stake in Global Blood Therapeutics Inc (NASDAQ:GBT) by 4.4% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Co
We're looking at some of the biggest issues affecting black lives in Britain today
Geode Capital Management LLC increased its stake in Global Blood Therapeutics Inc (NASDAQ:GBT) by 7.5% in the 1st quarter, according to the company in its most recent filing with the SEC. The institut
NAIROBI, Kenya, Jun 20 – Patients with sickle-cell disease (SCD) face a higher risk of contracting and suffering severe COVID-19 due to their low immunity resulting from the blood disorder, the heal
Global Blood Therapeutics Inc (NASDAQ:GBT) was the recipient of some unusual options trading activity on Thursday. Stock investors purchased 1,979 put options on the stock. This represents an increase
The Nigeria Orthopaedic Association has called on the Federal Government to subsidise and provide Medical Insurance for people living with sickle cell disease in Nigeria. The call was made by Kunle Ol
To mark this year’s World Sickle Cell day, Nigerians in Diaspora in partnership with Brain & Body Foundation offered medical support as well as awareness to people living with sickle cell disease in
Nigerian Orthopaedic Association says an estimated 250 million people across the world are currently suffering from Sickle Cell Disease...
The Nigerian Orthopaedic Association, NOA , has revealed that an estimated 250million people across the globe were currently suffering from Sickle Cell Disease (SCD).
Mr Munda said that in order to collect real-time data and provide relevant information related to Sickle Cell, the government has launched a new portal which will act as a catalyst in creating awarene

Sickle cell: A disease that discriminates

05:01am, Friday, 19'th Jun 2020
There is no national, funded centre for the treatment of this serious blood disorder
BOULDER, Colo., June 18, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, to
Experts have called for the need to focus on caring for sickle cell carriers, saying the lack of proper sensitisation on the importance of genotype testing has led to what could have been prevented by
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE